- Home
- FWRD vs CATX Comparison
FWRD vs CATX Comparison
Compare FWRD & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWRD | CATX |
|---|---|---|
| Founded | 1981 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.4M | 569.6M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FWRD | CATX |
|---|---|---|
| Price | $17.29 | $4.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $38.50 | $12.11 |
| AVG Volume (30 Days) | 738.8K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,269,573,000.00 | N/A |
| Revenue This Year | $6.57 | $12.71 |
| Revenue Next Year | $6.66 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.79 | $1.60 |
| 52 Week High | $32.47 | $6.16 |
Technical Indicators
Market Signals| Indicator | FWRD | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 38.12 | 47.58 |
| Support Level | $15.75 | $3.24 |
| Resistance Level | $23.20 | $4.64 |
| Average True Range (ATR) | 0.81 | 0.36 |
| MACD | 0.41 | -0.06 |
| Stochastic Oscillator | 86.34 | 40.00 |
Price Performance
Historical ComparisonAbout FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.